In addition, Pat thinks then beginner investors should cultivate two important qualities: a healthy sense of skepticism and patience.
[text_ad]
Investors should approach all investments with a healthy sense of skepticism. This can help keep you out of fraudulent stocks that masquerade as high-quality stocks. It will also keep you out of legally operated, but poorly managed, companies that promise more than they can possibly deliver.
If you are a new investor, you should also realize that losing patience can cause you to sell your best choices right before a big rise. All too often, investors buy a promising stock just as it enters a period of price stagnation. Even the best-performing stocks run into these unpredictable phases from time to time. They move mainly sideways in a wide range for months or years before their next big rise begins. (Stock brokers often refer to these stocks as “dead money.”)
If you lack patience, you run a big risk of selling your best choices in the midst of one of these phases, prior to the next big move upward. If you lose patience and sell, you are particularly likely to do so in the low end of the trading range, when stock prices have weakened and confidence in the stock has waned.
[text_ad]
In fact, dividends can now contribute up to a third of your long-term investment returns, without even considering the tax-cutting effects of the dividend tax credit (see below).
In addition, dividends are far more reliable than capital gains. A stock that pays a $1 dividend this year will probably do the same next year. It may even increase its dividend payment.
Canadian dividends give you tax advantages
Taxpayers who hold dividend-paying Canadian stocks get an additional bonus: their dividends can be eligible for the dividend tax credit in Canada.
...
However, if you do want to speculate on a Greek recovery, one way to do it is through the Global X FTSE Greece 20 ETF, $9.46, symbol GREK on New York (Units outstanding: 31.1 million; Market cap: $294.2 million; www.globalxfunds.com).
This fund holds 20 stocks and has a 0.61% MER....
Baxter handed out 80.5% of its Baxalta shares to its investors on July 1, 2015, on a one-for-one basis. This new company makes biopharmaceuticals, including vaccines and hemophilia drugs. Baxter plans to sell or distribute the remaining 19.5% over the next five years.
Now that the spinoff is complete, Baxter will focus on medical devices, such as intravenous pumps and kidney-dialysis equipment.
Your Baxalta shares should soon appear on your brokerage statements. Baxter is still a buy.
We’ll say more about Baxalta in the next issue of Wall Street Stock Forecaster, but for now it’s a hold.
...
The company has six plants: four in the U.S. and two in Canada. It also owns 75.3% of Terra Nitrogen, which makes nitrogen fertilizers at an Oklahoma facility, and operates fertilizer plants in the U.K. and Trinidad through joint ventures.
In March 2014, CF sold its phosphate mining and manufacturing operations to Mosaic Co., symbol MOS on New York, for $1.4 billion. That’s the main reason why its revenue declined 15.8% in the three months ended March 31, 2015, to $953.6 million from $1.1 billion a year earlier.
Earnings fell 62.9%, to $0.96 from $2.58 (all per-share amounts adjusted for a 5-for-1 stock split in June 2015). Excluding unusual items, such as a gain on the sale of the phosphate business, per-share profits were unchanged at $0.97.
CF recently agreed to pay $580 million for the 50% of a U.K.-based joint venture that it doesn’t already own. The deal will close later this year. This business accounts for 40% of the U.K.’s fertilizer market.
...